Aigen Investment Management’s Ezcorp Inc EZPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-52,054
Closed -$991K 715
2025
Q3
$991K Sell
52,054
-8,912
-15% -$140K 0.15% 201
2025
Q2
$846K Buy
60,966
+37,497
+160% +$542K 0.12% 277
2025
Q1
$345K Buy
23,469
+3,669
+19% +$48.4K 0.06% 457
2024
Q4
$242K Buy
19,800
+2,088
+12% +$24.8K 0.04% 548
2024
Q3
$199K Buy
17,712
+2,508
+16% +$27.4K 0.04% 590
2024
Q2
$159K Buy
15,204
+2,640
+21% +$27.8K 0.03% 651
2024
Q1
$142K Sell
12,564
-27,874
-69% -$275K 0.03% 581
2023
Q4
$353K Buy
40,438
+7,416
+22% +$62.2K 0.06% 439
2023
Q3
$272K Buy
33,022
+22,131
+203% +$190K 0.05% 552
2023
Q2
$91.3K Buy
+10,891
New +$94.4K 0.01% 681
2021
Q2
Sell
-20,841
Closed -$104K 556
2021
Q1
$104K Sell
20,841
-4,706
-18% -$23.6K 0.01% 584
2020
Q4
$122K Buy
+25,547
New +$128K 0.02% 721
2020
Q3
Sell
-22,196
Closed -$140K 926
2020
Q2
$140K Sell
22,196
-81,677
-79% -$440K 0.02% 737
2020
Q1
$433K Buy
103,873
+40,587
+64% +$209K 0.06% 464
2019
Q4
$432K Buy
+63,286
New +$363K 0.07% 354

Other funds holding EZPW

Aigen Investment Management's EZPW Position: Q4 2025 in Review

Aigen Investment Management sold out of Ezcorp Inc (EZPW) in Q4 2025, closing a stake of 52,054 shares — an estimated $991K sold.

Aigen Investment Management first reported a position in EZPW in Q4 2019 and held it in 15 quarters. The position peaked at $991K in Q3 2025. 258 funds tracked by Wall St. Rank hold EZPW as of Q4 2025.

  • Aigen Investment Management reported no remaining Ezcorp Inc position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 52,054 Ezcorp Inc shares in Q4 2025, an estimated $991K.
  • Aigen Investment Management first reported a position in Ezcorp Inc in Q4 2019 and held it in 15 quarters.
  • Aigen Investment Management's Ezcorp Inc position peaked at $991K in Q3 2025.
  • 258 funds tracked by Wall St. Rank held Ezcorp Inc as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.